Tenet Reports Results for the Second Quarter Ended June 30, 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Tenet Healthcare (THC) Tops Q2 EPS by 12c, Revenues Beat; Offers Q3 & FY19 EPS/Revenue Guidance
August 5, 2019 4:25 PM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $0.56, $0.12 better than the analyst estimate of $0.44. Revenue for the quarter came in at $4.56 billion versus the consensus estimate of $4.48 billion.
Tenet reported net income from continuing operations attributable to Tenet common shareholders of $15 million or $0.14 per diluted share in the second quarter of 2019 compared to $24 million or $0.23 per diluted share in the second quarter of 2018.Adjusted diluted earnings per share from continuing operations were $0.56 in the second quarter of 2019, above the midpoint of the Companys Outlook and compared to $0.49 in the second... More